SequelSEC

Healthcare Triangle, Inc. HCTI

Services-Computer Integrated Systems Design · CIK 0001839285 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$13.89M
Fiscal year ended 2025-12-31
Operating income
-$9.79M
Fiscal year ended 2025-12-31
Free cash flow
-$16.53M
Fiscal year ended 2025-12-31

Healthcare Triangle, Inc. (HCTI) reported revenue of $13.89M and net income of -$9.48M for the fiscal year ended 2025-12-31. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from Healthcare Triangle, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Computer Integrated Systems Design.

Income

Healthcare Triangle, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Revenue$13.89M$11.70M$33.20M$45.89M$35.27M$31.34M
Cost of revenueUnavailableUnavailableUnavailable$34.59M$24.75M$22.75M
Gross profitUnavailableUnavailableUnavailable$11.30M$10.52M$8.59M
Operating income-$9.79M-$4.75M-$7.70M-$16.32M-$5.36M$1.18M
Net income-$9.48M-$5.97M-$8.69M-$14.36M-$5.95M$2.35M
Research & development$536.00K$429.00K$799.00K$8.14M$5.26M$1.74M
Weighted-average diluted sharesUnavailableUnavailableshares 4.18Mshares 3.70Mshares 29.43Mshares 27.90M
Pretax income-$9.48M-$5.96M-$8.65M-$13.85M-$5.92M$2.61M
Income tax expenseUnavailable$12.00K$35.00K$506.00K$24.00K$257.38K
Diluted EPS$-152.30$-16,909.30$-2.08$-3.88$-0.20$0.08
Selling, general & administrative$10.42M$6.15M$10.40M$0$0Unavailable
General & administrative$7.34M$3.95M$5.73M$5.52M$4.44M$2.44M
Selling & marketing$3.08M$2.20M$4.67M$6.65MUnavailableUnavailable

Balance

Healthcare Triangle, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Cash & equivalents$7.62M$20.00K$1.23M$1.34M$1.77M$1.40M
Total assets$22.74M$1.96M$6.86M$13.26M$24.61M$11.11M
Current assets$13.15M$1.45M$5.65M$8.02M$11.80M$8.03M
Total liabilities$12.79M$7.08M$8.25M$7.22M$8.48M$6.78M
Current liabilities$12.79M$7.08M$8.15M$6.60M$6.25M$6.78M
Total equity incl. NCI$9.94M-$5.11M-$1.39M$6.04M$14.24M$4.33M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$2.07M$1.11M$3.60M$5.86M$9.67M$6.40M
Goodwill$2.95MUnavailableUnavailable$1.29M$1.29MUnavailable
Long-term debtUnavailableUnavailable$888.00KUnavailableUnavailableUnavailable
Accounts payable$744.00K$2.54M$1.95M$1.48M$1.87M$4.35M

Cash flow

Healthcare Triangle, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Operating cash flow-$16.52M-$1.08M-$2.15M-$5.35M-$7.11M-$734.68K
Capital expenditures$6.00KUnavailable$12.00K$40.00KUnavailableUnavailable
Investing cash flow-$1.75MUnavailable-$12.00K-$1.13M-$7.63M-$477.46K
Financing cash flow$25.88M-$133.00K$2.06M$6.06M$15.11M$1.64M
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Stock-based compensation$451.00K$87.00K$166.00K$257.00KUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailable$141.00KUnavailableUnavailable
Depreciation & amortization$705.00K$889.00K$1.57M$2.94M$1.42M$803.19K

Derived

Healthcare Triangle, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Free cash flow-$16.53MUnavailable-$2.16M-$5.39MUnavailableUnavailable
Gross margin8890.6%UnavailableUnavailable24.6%29.8%27.4%
Operating margin-70.5%-40.6%-23.2%-35.6%-15.2%3.8%
FCF margin-119.0%Unavailable-6.5%-11.8%UnavailableUnavailable
SBC / revenue3.2%0.7%0.5%0.6%UnavailableUnavailable
Current ratio1.03x0.21x0.69x1.22x1.89x1.18x
Revenue YoY growth18.8%-64.8%-27.6%30.1%12.5%Unavailable
Net margin-68.2%-51.0%-26.2%-31.3%-16.9%7.5%
R&D / revenue3.9%3.7%2.4%17.7%14.9%5.6%
CapEx / revenue0.0%Unavailable0.0%0.1%UnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailable9.9%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HCTI in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K/A · Filed 2026-04-16View SEC filing
10-K · Filed 2026-04-15View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-14View SEC filing

Companies in the same industry

AGYS ASUR AUR BNAI CACI CREX CSPI DAIC FUSE FVN GDDY GRHI

Reconciliation checks needing review

4 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2025-12-31

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-12-31

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2023-12-31

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.

balance equationreview2021-12-31

Difference 1894000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.